Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies... Research Beam Model: Research Beam Product ID: 1136160 125 USD New
Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review
 
 

Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review

  • Category : Pharmaceuticals
  • Published On : October   2016
  • Pages : 53
  • Publisher : GlobalData
 
 
 
Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Arena Pharmaceuticals, Inc., (Arena) is a bio-pharmaceutical company which discovers, develops and commercializes drugs that target its patented G protein-coupled receptors (GPCRs). The company’s lead product, BELVIQ (lorcaserin HCl), is used for chronic weight management for adults who are either overweight with co-morbidity or obese. Its pipeline portfolio encompasses Temanogrel for the treatment of thrombotic diseases; Ralinepag for the treatment of vascular diseases including pulmonary arterial hypertension; APD334 targeted against autoimmune diseases; and APD371 for pain management. The company markets BELVIQ in the US in collaboration with Eisai and in South Korea in collaboration with Ildong. It operates commercial manufacturing facility in Zofingen, Switzerland. Arena is headquartered in San Diego, California, the US.

Arena Pharmaceuticals, Inc. Key Recent Developments

Sep 01, 2016: Arena Pharmaceutics Announces Formation of Beacon Discovery
Aug 15, 2016: Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
Aug 08, 2016: Arena Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Jun 30, 2016: Arena Pharmaceuticals Announces Shift to Focus on Proprietary Clinical Stage Pipeline
Jun 15, 2016: Arena Pharmaceuticals Announces Appointment of Kevin R. Lind as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Arena Pharmaceuticals, Inc. - Key Facts 6
Arena Pharmaceuticals, Inc. - Key Employees 7
Arena Pharmaceuticals, Inc. - Key Employee Biographies 8
Arena Pharmaceuticals, Inc. - Major Products and Services 9
Arena Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data 10
Arena Pharmaceuticals, Inc., Pipeline Products by Therapy Area 10
Arena Pharmaceuticals, Inc., Pipeline Products by Development Phase 11
Arena Pharmaceuticals, Inc. - History 13
Arena Pharmaceuticals, Inc. - Company Statement 17
Arena Pharmaceuticals, Inc. - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Section 2 – Company Analysis 23
Arena Pharmaceuticals, Inc. - Business Description 23
Arena Pharmaceuticals, Inc. - Corporate Strategy 24
Arena Pharmaceuticals, Inc. - SWOT Analysis 25
SWOT Analysis - Overview 25
Arena Pharmaceuticals, Inc. - Strengths 25
Strength - Lead Product: BELVIQ 25
Strength - Research and Development Activities 25
Arena Pharmaceuticals, Inc. - Weaknesses 26
Weakness - Operating Loss Carryforward 26
Weakness - Product Safety Concerns 26
Arena Pharmaceuticals, Inc. - Opportunities 27
Opportunity - Agreement with Boehringer Ingelheim 27
Opportunity - Changing Demographics 27
Opportunity - Market Potential: Obesity 27
Arena Pharmaceuticals, Inc. - Threats 28
Threat - Stiff Competition 28
Threat - Uncertain R&D Outcomes 28
Threat - Stringent Government Regulation 28
Arena Pharmaceuticals, Inc. - Key Competitors 29
Section 3 – Company Financial Ratios 30
Financial Ratios - Capital Market Ratios 30
Financial Ratios - Annual Ratios 31
Performance Chart 32
Financial Performance 32
Financial Ratios - Interim Ratios 33
Financial Ratios - Ratio Charts 34
Section 4 – Company’s Lifesciences Financial Deals and Alliances 35
Arena Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 35
Arena Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 36
Arena Pharmaceuticals, Inc., Recent Deals Summary 37
Section 5 – Company’s Recent Developments 38
Sep 01, 2016: Arena Pharmaceutics Announces Formation of Beacon Discovery 38
Aug 15, 2016: Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer 39
Aug 08, 2016: Arena Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update 40
Jun 30, 2016: Arena Pharmaceuticals Announces Shift to Focus on Proprietary Clinical Stage Pipeline 41
Jun 15, 2016: Arena Pharmaceuticals Announces Appointment of Kevin R. Lind as Chief Financial Officer 42
May 09, 2016: Arena Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update 43
May 09, 2016: Arena Pharmaceuticals Announces Appointment of Amit D. Munshi as President and Chief Executive Officer 44
Feb 29, 2016: Arena Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update 45
Nov 10, 2015: Arena Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update 47
Oct 27, 2015: Arena Pharmaceuticals Announces New Strategic Focus and Cost Reduction Plan 48
Section 6 – Appendix 49
Methodology 49
Ratio Definitions 49
About GlobalData 53
Contact Us 53
Disclaimer 53List of Tables
Arena Pharmaceuticals, Inc., Key Facts 6
Arena Pharmaceuticals, Inc., Key Employees 7
Arena Pharmaceuticals, Inc., Key Employee Biographies 8
Arena Pharmaceuticals, Inc., Major Products and Services 9
Arena Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area 10
Arena Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage 11
Arena Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase 12
Arena Pharmaceuticals, Inc., History 13
Arena Pharmaceuticals, Inc., Subsidiaries 22
Arena Pharmaceuticals, Inc., Key Competitors 29
Arena Pharmaceuticals, Inc., Ratios based on current share price 30
Arena Pharmaceuticals, Inc., Annual Ratios 31
Arena Pharmaceuticals, Inc., Interim Ratios 33
Arena Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 35
Arena Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 36
Arena Pharmaceuticals, Inc., Recent Deals Summary 37
Currency Codes 49
Capital Market Ratios 49
Equity Ratios 50
Profitability Ratios 50
Cost Ratios 51
Liquidity Ratios 51
Leverage Ratios 52
Efficiency Ratios 52List of Figures
Arena Pharmaceuticals, Inc., Pipeline Products by Therapy Area 10
Arena Pharmaceuticals, Inc., Pipeline Products by Development Phase 11
Arena Pharmaceuticals, Inc., Performance Chart (2011 - 2015) 32
Arena Pharmaceuticals, Inc., Ratio Charts 34
Arena Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 35
Arena Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 36
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter